IMSAInternational Medical Sciences Academy

JIMSA › Vol 36 No 3 · July–September 2023

Original Articles · pages 288–292

Flavonoid Fraction (500 mg) in the Management of Bleeding Hemorrhoids: A Prospective, Observer-Blind, Randomized, Comparative Study

Siddharth Sarnaik

Cite this article

Siddharth Sarnaik. Flavonoid Fraction (500 mg) in the Management of Bleeding Hemorrhoids: A Prospective, Observer-Blind, Randomized, Comparative Study. J Int Med Sci Acad. 2023;36(3):288–292.

Opening of the article

Background: Hemorrhoids are very common with a prevalence of about 50% between the age of 45 to 65 years. Bleeding and pruritus are the most typical symptoms in patients with hemorrhoids and the reason why patients seek consultation from Colo-rectal surgeons. With availability of several therapies, there is a need to find comparative effectiveness of drugs prescribed in the management of presenting signs and symptoms. Objective: Compare the efficacy and safety of Euphorbia Prostrata (EP) dry extract with micronized purified flavonoid fraction (MPFF) in patients with bleeding hemorrhoids.

Keywords
Euphorbia Prostrata, Micronized Purified Flavonoid Fraction, Observer-Blind, Randomized, bleeding is one of the most commonly problem

Published July–September 2023 · Free to read